Cargando…

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable cardiomyopathy characterized by a predominantly arrhythmic presentation. It represents the leading cause of sudden cardiac death (SCD) among athletes and poses a significant morbidity threat in the general population. As a causati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gasperetti, Alessio, James, Cynthia A, Carrick, Richard T, Protonotarios, Alexandros, te Riele, Anneline S J M, Cadrin-Tourigny, Julia, Compagnucci, Paolo, Duru, Firat, van Tintelen, Peter, Elliot, Perry M, Calkins, Hugh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674106/ https://www.ncbi.nlm.nih.gov/pubmed/37935403 http://dx.doi.org/10.1093/europace/euad312

Ejemplares similares

Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy
por: van der Voorn, Stephanie M, et al.
Publicado: (2020)

Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study
por: Gasperetti, Alessio, et al.
Publicado: (2022)

Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2018)

Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity
por: te Riele, Anneline S. J. M., et al.
Publicado: (2021)

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator( )
por: Jordà, Paloma, et al.
Publicado: (2022)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Keeping balance: Author’s reply
por: Bosman, Laurens P, et al.
Publicado: (2020)

Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
por: Bosman, Laurens P, et al.
Publicado: (2021)

Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation
por: Bosman, Laurens P, et al.
Publicado: (2020)

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wallace, Ryan, et al.
Publicado: (2021)

Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy
por: Ren, Jie, et al.
Publicado: (2020)

Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy
por: van der Voorn, Stephanie M., et al.
Publicado: (2023)

Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update
por: te Riele, Anneline SJM, et al.
Publicado: (2014)

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
por: Protonotarios, Alexandros, et al.
Publicado: (2020)

Advancing the science of management of arrhythmic disease in children and adult congenital heart disease patients within the last 25 years
por: Paul, Thomas, et al.
Publicado: (2023)

Arrhythmic Manifestations of Cardiac Amyloidosis: Challenges in Risk Stratification and Clinical Management
por: Laptseva, Natallia, et al.
Publicado: (2023)

Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis
por: Corrado, Domenico, et al.
Publicado: (2020)

Risk stratification of sudden cardiac death: a review
por: Tfelt-Hansen, Jacob, et al.
Publicado: (2023)

Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy
por: Hodes, Anke R, et al.
Publicado: (2016)

Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2020)

Genetic Risk Stratification: A Paradigm Shift in Prevention of Coronary Artery Disease
por: Roberts, Robert, et al.
Publicado: (2021)

Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
por: Murray, Brittney, et al.
Publicado: (2018)

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy( )
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2022)

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications
por: Orgeron, Gabriela M., et al.
Publicado: (2017)

International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
por: James, Cynthia A., et al.
Publicado: (2021)

Exercise has a Disproportionate Role in the Pathogenesis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in Patients Without Desmosomal Mutations
por: Sawant, Abhishek C., et al.
Publicado: (2014)

Leveling the playing field: The utility of coronary artery calcium scoring in cardiovascular risk stratification in South Asians
por: Agarwala, Anandita, et al.
Publicado: (2022)

Familial Arrhythmogenic Cardiomyopathy: Clinical Determinants of Phenotype Discordance and the Impact of Endurance Sports
por: Costa, Sarah, et al.
Publicado: (2020)

Late evolution of arrhythmogenic cardiomyopathy in patients with initial presentation as idiopathic ventricular fibrillation
por: Blom, Lennart J., et al.
Publicado: (2018)

Retracted and Republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2019)

Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia/cardiomyopathy: prevalence, patterns, and association with arrhythmias
por: Zghaib, Tarek, et al.
Publicado: (2021)

Quantitative Approach to Fragmented QRS in Arrhythmogenic Cardiomyopathy: From Disease towards Asymptomatic Carriers of Pathogenic Variants
por: Roudijk, Rob W., et al.
Publicado: (2020)

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
por: Orgeron, Gabriela M., et al.
Publicado: (2018)

From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
por: Crotti, Lia, et al.
Publicado: (2023)

Efficacy of Catheter Ablation for Atrial Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy—A Multicenter Study
por: Gasperetti, Alessio, et al.
Publicado: (2021)

Clinical update on pulmonary embolism
por: Duru, Serap, et al.
Publicado: (2013)

Arrhythmogenic Right Ventricular Cardiomyopathy in a Pediatric Patient
por: Roudijk, Rob W., et al.
Publicado: (2020)

Predicting Ventricular Tachycardia Circuits in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy using Genotype-specific Heart Digital Twins
por: Zhang, Yingnan, et al.
Publicado: (2023)

Circadian and Seasonal Pattern of Arrhythmic Events in Arrhythmogenic Cardiomyopathy Patients
por: Castelletti, Silvia, et al.
Publicado: (2023)

Validation of an Arrhythmogenic Right Ventricular Cardiomyopathy Risk-Prediction Model in a Chinese Cohort
por: Zhang, Nixiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69avr8u7t4b0p86b373pbfnmdd